ArticleThe pharmacogenomics journal2013

Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin.

I Iacobucci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.